相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Role of MIF and D-DT in immune-inflammatory, autoimmune, and chronic respiratory diseases: from pathogenic factors to therapeutic targets
Sven Gunther et al.
DRUG DISCOVERY TODAY (2019)
Optimising experimental research in respiratory diseases: an ERS statement
Philippe Bonniaud et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Dasatinib increases endothelial permeability leading to pleural effusion
Carole Phan et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Ectopic upregulation of membrane-bound IL6R drives vascular remodeling in pulmonary arterial hypertension
Yuichi Tamura et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Design, Synthesis, and Biological Activity of New &ITN&IT-(Phenylmethyl)-benzoxazol-2-thiones as Macrophage Migration Inhibitory Factor (MIF) Antagonists: Efficacies in Experimental Pulmonary Hypertension
Morane Le Hiress et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Advances and Insights for Small Molecule Inhibition of Macrophage Migration Inhibitory Factor
Vinay Trivedi-Parmar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Diagnosis of Idiopathic Pulmonary Fibrosis An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis
Andreas Guenther et al.
RESPIRATORY RESEARCH (2018)
An MIF Promoter Polymorphism Is Associated with Susceptibility to Pulmonary Arterial Hypertension in Diffuse Cutaneous Systemic Sclerosis
Lara Bossini-Castillo et al.
JOURNAL OF RHEUMATOLOGY (2017)
Irregularities in enzyme assays: The case of macrophage migration inhibitory factor
Jose A. Cisneros et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Macrophage migration inhibitory factor in lung tissue of idiopathic pulmonary fibrosis patients
Carmela Olivieri et al.
EXPERIMENTAL LUNG RESEARCH (2016)
MIF, a controversial cytokine: a review of structural features, challenges, and opportunities for drug development
Joshua Bloom et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2016)
Macrophage Migration Inhibitory Factor-CXCR4 Receptor Interactions EVIDENCE FOR PARTIAL ALLOSTERIC AGONISM IN COMPARISON WITH CXCL12 CHEMOKINE
Deepa Rajasekaran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension
Christophe Guignabert et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Inhibition of Macrophage Migration Inhibitory Factor Protects against Inflammation and Matrix Deposition in Kidney Tissues after Injury
Hong Lu et al.
MEDIATORS OF INFLAMMATION (2016)
Proinflammatory Signature of the Dysfunctional Endothelium in Pulmonary Hypertension Role of the Macrophage Migration Inhibitory Factor/CD74 Complex
Morane Le Hiress et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
SERUM LEVELS, TISSUE EXPRESSION AND CELLULAR SECRETION OF MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) IN LIMITED AND DIFFUSE SYSTEMIC SCLEROSIS
C. Corallo et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
An Analysis of MIF Structural Features that Control Functional Activation of CD74
Georgios Pantouris et al.
CHEMISTRY & BIOLOGY (2015)
Leptin signalling system as a target for pulmonary arterial hypertension therapy
Alice Huertas et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Nazzareno Galie et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
The Role of Macrophage Migration Inhibitory Factor in Mast Cell-Stimulated Fibroblast Proliferation and Collagen Production
Gu Ningyan et al.
PLOS ONE (2015)
Antifibrotic and Anti-inflammatory Activity of the Tyrosine Kinase Inhibitor Nintedanib in Experimental Models of Lung Fibrosis
Lutz Wollin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Genetic studies provide clues on the pathogenesis of idiopathic pulmonary fibrosis
Jonathan A. Kropski et al.
DISEASE MODELS & MECHANISMS (2013)
Dysregulated Renin-Angiotensin-Aldosterone System Contributes to Pulmonary Arterial Hypertension
Frances S. de Man et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
A Critical Role for p130Cas in the Progression of Pulmonary Hypertension in Humans and Rodents
Ly Tu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Macrophage Migration Inhibitory Factor Mediates Hypoxia-Induced Pulmonary Hypertension
Yinzhong Zhang et al.
MOLECULAR MEDICINE (2012)
Role of Macrophage Migration Inhibitory Factor in the Proliferation of Smooth Muscle Cell in Pulmonary Hypertension
Bo Zhang et al.
MEDIATORS OF INFLAMMATION (2012)
Autocrine Fibroblast Growth Factor-2 Signaling Contributes to Altered Endothelial Phenotype in Pulmonary Hypertension
Ly Tu et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2011)
MIF as a disease target: ISO-I as a proof-of-concept therapeutic
Yousef Al-Abed et al.
FUTURE MEDICINAL CHEMISTRY (2011)
Antifibrotic activities of pirfenidone in animal models
C. J. Schaefer et al.
EUROPEAN RESPIRATORY REVIEW (2011)
A robust collagen scoring method for human liver fibrosis by second harmonic microscopy
Thomas Guilbert et al.
OPTICS EXPRESS (2010)
VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats
Laszlo Farkas et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Monocyte Chemoattractant Protein-1 (MCP-1): An Overview
Satish L. Deshmane et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2009)
Elevated Serum Macrophage Migration Inhibitory Factor (MIF) Concentrations in Chronic Kidney Disease (CKD) Are Associated with Markers of Oxidative Stress and Endothelial Activation
Annette Bruchfeld et al.
MOLECULAR MEDICINE (2009)
Analysis of macrophage migration inhibitory factor (MIF) in patients with idiopathic pulmonary fibrosis
E. Bargagli et al.
RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY (2009)
The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis?
Antje Moeller et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
Pulmonary vascular lesions in end-stage idiopathic pulmonary fibrosis: histopathologic study on lung explant specimens and correlations with pulmonary hemodynamics
Magali Colombat et al.
HUMAN PATHOLOGY (2007)
Role of macrophage migration inhibitory factor in bleomycin-induced lung injury and fibrosis in mice
Y Tanino et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2002)
Time course of bleomycin-induced lung fibrosis
G Izbicki et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2002)
Bleomycin-induced chronic lung damage does not resemble human idiopathic pulmonary fibrosis
G Borzone et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1
R Kleemann et al.
NATURE (2000)
分享论文
